SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave

被引:5
作者
Pouquet, Marie [1 ]
Decarreaux, Dorine [1 ,2 ,3 ]
Di Domenico, Laura [1 ]
Sabbatini, Chiara E. [1 ]
Prevot-Monsacre, Pol [1 ]
Fourie, Toscane [3 ]
Villarroel, Paola Mariela Saba [3 ]
Priet, Stephane [3 ]
Blanche, Helene [4 ]
Sebaoun, Jean-Marc [4 ]
Deleuze, Jean-Francois [4 ]
Turbelin, Clement [1 ]
Rossignol, Louise [1 ]
Werner, Andreas [5 ]
Kochert, Fabienne [5 ]
Grosgogeat, Brigitte [6 ,7 ,8 ,9 ]
Rabiega, Pascaline [10 ]
Laupie, Julien [8 ]
Abraham, Nathalie [10 ]
Noel, Harold [11 ]
van der Werf, Sylvie [12 ,13 ]
Colizza, Vittoria [1 ]
Carrat, Fabrice [1 ,14 ]
Charrel, Remi [3 ,15 ]
de Lamballerie, Xavier [3 ]
Blanchon, Thierry [1 ]
Falchi, Alessandra [2 ,3 ]
机构
[1] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ IPLESP, INSERM, F-75012 Paris, France
[2] Univ Corse Pascal Paoli, Lab Virol, UR7310 Bioscope, F-20250 Corte, France
[3] Aix Marseille Univ, Unite Virus Emergents, INSERM, IRD 190,U1207, F-13005 Marseille, France
[4] Fdn Jean Dausset CEPH, F-75010 Paris, France
[5] Assoc Francaise Pediat Ambulatoire AFPA, 155 Rue Edouard Branly, F-44150 Ancenis St Gereon, France
[6] Univ Claude Bernard Lyon 1, Univ Lyon, Fac Odontol, F-69000 Lyon, France
[7] Univ Claude Bernard Lyon 1, Univ Lyon, UMR CNRS 5615, Lab Multimat & Interfaces, F-69000 Lyon, France
[8] Assoc Dent Francaise, Reseau ReCOL, F-75000 Paris, France
[9] Hosp Civils Lyon, Serv Odontol, F-69007 Lyon, France
[10] IQVIA, Reseau Pharmaciens, F-75000 Paris, France
[11] Sante Publ France, Infect Dis Div, F-94410 St Maurice, France
[12] Univ Paris, CNRS, Inst Pasteur, Mol Genet RNA Viruses Unit,UMR 3569, Paris, France
[13] Univ Paris Cite, Inst Pasteur, Natl Reference Ctr Resp Viruses, F-75015 Paris, France
[14] Sorbonne Univ, Hop St Antoine, AP HP, Dept Sante Publ, Paris, France
[15] Hop Univ Marseille, LE Serv Prevent Risque Infect LESPRI, CLIN AP HM, F-13005 Marseille, France
关键词
SARS-CoV-2; COVID-19; Healthcare workers; Primary healthcare; General population; Prevalence; Risk factors; SEROPREVALENCE; ANTIBODIES; HOSPITALS;
D O I
10.1038/s41598-024-55477-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on the SARS-CoV-2 infection among primary health care workers (PHCWs) are scarce but essential to reflect on policy regarding prevention and control measures. We assessed the prevalence of PHCWs who have been infected by SARS-CoV-2 in comparison with modeling from the general population in metropolitan France, and associated factors. A cross-sectional study was conducted among general practitioners (GPs), pediatricians, dental and pharmacy workers in primary care between May and August 2021. Participants volunteered to provide a dried-blood spot for SARS-CoV-2 antibody assessment and completed a questionnaire. The primary outcome was defined as the detection of infection-induced antibodies (anti-nucleocapsid IgG, and for non-vaccinees: anti-Spike IgG and neutralizing antibodies) or previous self-reported infection (positive RT-qPCR or antigenic test, or positive ELISA test before vaccination). Estimates were adjusted using weights for representativeness and compared with prediction from the general population. Poisson regressions were used to quantify associated factors. The analysis included 1612 PHCWs. Weighted prevalences were: 31.7% (95% CI 27.5-36.0) for GPs, 28.7% (95% CI 24.4-33.0) for pediatricians, 25.2% (95% CI 20.6-31.0) for dentists, and 25.5% (95% CI 18.2-34.0) for pharmacists. Estimates were compatible with model predictions for the general population. PHCWs more likely to be infected were: GPs compared to pharmacist assistants (adjusted prevalence ratio [aPR] = 2.26; CI 95% 1.01-5.07), those living in ile-de-France (aPR = 1.53; CI 95% 1.14-2.05), South-East (aPR = 1.57; CI 95% 1.19-2.08), North-East (aPR = 1.81; CI 95% 1.38-2.37), and those having an unprotected contact with a COVID-19 case within the household (aPR = 1.48; CI 95% 1.22-1.80). Occupational factors were not associated with infection. In conclusion, the risk of SARS-CoV-2 exposure for PHCWs was more likely to have occurred in the community rather than at their workplace.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Watheq Thabet Taher
    Amen A. Bawazir
    Talal A. Sallam
    Khaled Alsurimi
    BMC Infectious Diseases, 23
  • [22] A case-control study of factors associated with SARS-CoV-2 infection among healthcare workers in Colombia
    Rodriguez-Lopez, Merida
    Parra, Beatriz
    Vergara, Enrique
    Rey, Laura
    Salcedo, Mercedes
    Arturo, Gabriela
    Alarcon, Liliana
    Holguin, Jorge
    Osorio, Lyda
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [23] SARS-CoV-2 infection among primary healthcare workers: a cross-sectional study
    Qotba, Hamda Abdulla A.
    Hamed, Ehab
    Alnuaimi, Ahmed Sameer
    Saad, Azza Awad
    Nasrallah, Gheyath K.
    Alnaama, Abdulla Abdulrahman
    Syed, Mohamed Ahmed
    GERMS, 2021, 11 (02): : 324 - 328
  • [24] Asymptomatic SARS-CoV-2 infection among healthcare workers in a non-COVID-19 teaching university hospital
    Mukhtar, Ahmed
    Afishawy, Mostafa
    Alkhatib, Engy
    Hosny, Moushira
    Ollaek, Mohamed
    Elsayed, Amal
    Salem, Marwa Rashad
    Ghaith, Doaa
    JOURNAL OF PUBLIC HEALTH RESEARCH, 2021, 10 (03)
  • [25] Factors Associated with SARS-CoV-2 Infection Risk among Healthcare Workers of an Italian University Hospital
    Modenese, Alberto
    Casolari, Loretta
    Rossi, Giorgia
    Della Vecchia, Elena
    Glieca, Francesca
    D'Elia, Cristiana
    Garavini, Denise
    Righi, Elena
    Mariani, Stefania
    Venturelli, Luca
    Vivoli, Daniela
    Gobba, Fabriziomaria
    HEALTHCARE, 2021, 9 (11)
  • [26] Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya
    Onchonga, David
    Omwoyo, Joshua
    Nyamamba, Duke
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (10) : 1149 - 1154
  • [27] The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
    Vaezi, Atefeh
    Fakhim, Hamed
    Abbasi, Saeed
    Masoudi, Soraya
    Rizi, Mahnaz Hosseini
    Javanmard, Shaghayegh Haghjooy
    ANTIBODIES, 2023, 12 (01)
  • [28] Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic
    Rodriguez, Adrian
    Arrizabalaga-Asenjo, Maria
    Fernandez-Baca, Victoria
    Pilar Lainez, Maria
    Al Nakeeb, Zaid
    Daniel Garcia, Jose
    Payeras, Antoni
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 482 - 486
  • [29] Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers
    Allen, Niamh
    Riain, Una Ni
    Conlon, Niall
    Ferenczi, Annamaria
    Carrion Martin, Antonio Isidro
    Domegan, Lisa
    Walsh, Cathal
    Doherty, Lorraine
    O'Farrelly, Cliona
    Higgins, Eibhlin
    Kerr, Colm
    McGrath, Jonathan
    Bergin, Colm
    Fleming, Catherine
    Fitzgerald, Margaret
    de Gascun, Cillian
    Gallagher, Joan
    Igoe, Derval
    Keogan, Mary
    Noonan, Noirin
    Rian, Una Ni
    Smyth, Breda
    Fleming, Catherine
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [30] Prevalence of SARS-COV-2 antibodies in the Thomayer University Hospital staff after the first wave of COVID-19
    Ibrahimova, M.
    Jamrikova, V.
    Sojka, P.
    Khaznadar, Z.
    Borecka, K.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2022, 71 (01): : 3 - 8